Gentris Corporation Submits FDA 510(k)
Gentris Corporation announced today that it has completed an FDA 510(k) submission and is planning to market six Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6).
Read MorePosted by Clinical Lab Products | Oct 26, 2006 | Cancer, Miscellaneous |
Gentris Corporation announced today that it has completed an FDA 510(k) submission and is planning to market six Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6).
Read MorePosted by Clinical Lab Products | Oct 10, 2006 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Digene President Resigns Charles M. Fleischman, Digene Corp’s president, COO, and CFO, is resigning from those positions as well as from the company’s board of directors. His resignation as CFO was effective October 1, when he
Read MorePosted by Clinical Lab Products | Sep 14, 2006 | Miscellaneous |
Companies Adeza Biomedical Corp Antek HealthWare LLC Audit MicroControls, Inc bioMérieux Ciphergen Biosystems Inc David G. Rhoads Associates Inc Genzyme Diagnostics Millipore Nanogen, Inc
Read MorePosted by Clinical Lab Products | Sep 14, 2006 | Cancer, Library Preparation Systems, Mass Spectrometry Reagents & Test Kits, Miscellaneous |
Researchers have devised a new method to detect a spectrum of known gene mutations in a variety of cancer genes that they say is both sensitive and cost-efficient.
Read MorePosted by Clinical Lab Products | Sep 7, 2006 | Miscellaneous |
Communicable diseases need a community in which to spread, and hospitals and other medical care facilities are infection havens. Crowded floors and immunocompromised patients are tourist traps for disease. Over time, each
Read More